Nucleosome Assembly: Mechanisms, Methods, and Common Pitfalls
By Dr. Zubair Khalid, DVM, MS, PhD ·
Introduction to Nucleosome Assembly
The Nucleosome as the Fundamental Unit of Chromatin
The nucleosome is the repeating structural unit of eukaryotic chromatin, consisting of approximately 147 base pairs of DNA wrapped around a histone octamer. This octamer contains two copies each of the core histones H2A, H2B, H3, and H4. The nucleosome is not merely a static packaging element; it is a dynamic platform that regulates DNA accessibility for transcription, replication, repair, and recombination. The Nucleosome Structure is characterized by a left-handed superhelix of DNA making 1.65 turns around the octamer, with histone N-terminal tails protruding outward for post-translational modification.
Nucleosome assembly is the process by which these DNA–histone complexes are formed. This process is essential for genome packaging, epigenetic inheritance, and maintenance of genomic stability. Errors in assembly lead to aberrant chromatin states, DNA damage, and developmental defects. Understanding the mechanisms of nucleosome assembly is therefore fundamental to molecular biology, with direct implications for gene regulation and disease.
Overview of Assembly Pathways
Nucleosome assembly occurs through two principal pathways in cells: replication-coupled assembly (RCA), which deposits histones onto newly synthesized DNA during S phase, and replication-independent assembly (RIA), which replaces or exchanges histones outside of DNA replication. Both pathways rely on histone chaperones—proteins that bind histones and prevent their non-specific aggregation with nucleic acids—and, in many cases, ATP-dependent chromatin remodelers that facilitate DNA wrapping and spacing.
The biochemical principles underlying nucleosome assembly are conserved: histones must be delivered in a controlled manner, DNA must be wrapped around the histone octamer in a stepwise fashion, and the final product must be a properly spaced, stable nucleosome. In vitro reconstitution systems have been instrumental in dissecting these principles, enabling researchers to assemble nucleosomes from purified components and study their properties under defined conditions.
Histone Chaperones and Their Roles
Histone chaperones are a diverse group of proteins that bind histones and shield their highly basic surfaces from non-specific electrostatic interactions with DNA. They are not ATP-dependent enzymes themselves; rather, they function as histone carriers and assembly factors. Major chaperones include CAF-1, HIRA, NAP1, and ASF1, each with distinct specificities and roles.
Replication-Coupled Assembly (RCA)
Chromatin assembly factor 1 (CAF-1) is the canonical RCA chaperone. It is a heterotrimeric complex comprising p150, p60, and p48 subunits in humans (encoded by CHAF1A, CHAF1B, and RBBP4, respectively). CAF-1 binds newly synthesized H3–H4 dimers and deposits them onto replicating DNA. Its recruitment to replication forks is mediated by the proliferating cell nuclear antigen (PCNA), the sliding clamp that encircles DNA during replication. CAF-1's p150 subunit interacts directly with PCNA, coupling histone deposition to DNA synthesis.
Anti-silencing function 1 (ASF1) is a conserved H3–H4 chaperone that functions upstream of CAF-1. ASF1 binds H3–H4 dimers and delivers them to CAF-1 for deposition. ASF1 also interacts with the histone acetyltransferase Hat1, which acetylates H4 on lysines 5 and 12—a modification associated with newly synthesized histones and important for their incorporation.
Replication-Independent Assembly (RIA)
The histone regulator A (HIRA) complex is the primary chaperone for replication-independent nucleosome assembly. HIRA is a trimeric complex containing HIRA, UBN1, and CABIN1. It deposits H3.3–H4 dimers, a histone variant that marks actively transcribed genes and regulatory elements. HIRA-mediated assembly occurs throughout the cell cycle and is particularly active at transcription start sites and enhancers, where nucleosomes are rapidly turned over.
Nucleosome assembly protein 1 (NAP1) is a chaperone for H2A–H2B dimers. NAP1 binds H2A–H2B and facilitates their incorporation into nucleosomes, both in RCA and RIA pathways. It also participates in histone exchange during transcription, removing and replacing H2A–H2B dimers as RNA polymerase traverses chromatin.
Other chaperones, such as FACT (facilitates chromatin transcription), are involved in both assembly and disassembly. FACT binds H2A–H2B and promotes nucleosome reorganization during transcription elongation, highlighting the dynamic nature of histone–chaperone interactions.
Step-by-Step Mechanism of Nucleosome Assembly
Histone Octamer Formation
The assembly of a nucleosome begins with the formation of a histone octamer from its constituent dimers and tetramers. In solution, histones exist primarily as H3–H4 tetramers and H2A–H2B dimers; a stable octamer only forms in the presence of DNA or high salt concentrations. The pathway proceeds as follows:
- H3–H4 tetramer formation: Two H3–H4 dimers associate through a four-helix bundle formed by the C-terminal domains of H3, creating a tetramer. This tetramer binds DNA with high affinity and is the first histone complex deposited onto DNA.
- H2A–H2B dimer binding: Two H2A–H2B dimers are added sequentially to the H3–H4 tetramer–DNA complex. Each dimer docks onto the tetramer through interactions between the H2B and H4 histone folds, completing the octamer.
- DNA wrapping: As histones assemble, DNA is progressively wrapped around the octamer. The final 147 bp wrap is achieved through a series of electrostatic contacts between the DNA phosphate backbone and basic residues on the histone surface.
The Histone Nucleosome interface is characterized by 14 direct contact points between the histone octamer and DNA, each involving arginine side chains that insert into the minor groove. These contacts are essential for nucleosome stability and are conserved across eukaryotes.
DNA-Histone Interactions and Wrapping
DNA wrapping around the histone octamer is energetically unfavorable due to the bending of the DNA helix. The free energy cost of bending is offset by electrostatic interactions between the positively charged histone residues and the negatively charged DNA backbone. Approximately 120 hydrogen bonds and over 300 van der Waals contacts stabilize the nucleosome.
The wrapping process is not random; it proceeds directionally from the nucleosome dyad outward. The H3–H4 tetramer binds the central 60–70 bp of DNA first, followed by the addition of H2A–H2B dimers, which stabilize the entry and exit points of DNA. This sequential assembly ensures that the nucleosome is formed with correct geometry and spacing.
Role of ATP-Dependent Chromatin Remodelers
ATP-dependent chromatin remodelers are not required for basic nucleosome assembly in vitro, but they are essential in vivo for proper nucleosome spacing and maturation. Remodelers such as ISWI, SWI/SNF, and CHD1 use the energy of ATP hydrolysis to slide nucleosomes along DNA, evict histones, or exchange histone variants.
During assembly, remodelers such as ISWI and CHD1 act as "spacers," ensuring that nucleosomes are positioned at regular intervals along the DNA. This spacing is critical for higher-order chromatin structure and for the accessibility of regulatory elements. In the absence of remodeler activity, nucleosomes assemble randomly, leading to irregular chromatin and gene misregulation. The mechanisms of Nucleosome Sliding involve the translocation of DNA relative to the histone octamer through a series of small steps, with each step corresponding to a single base pair.
In Vitro Nucleosome Assembly Methods
In vitro assembly of nucleosomes is a cornerstone technique in chromatin biology. It allows researchers to create defined nucleosome templates for biochemical, biophysical, and structural studies. Several methods exist, each with specific advantages and limitations.
Salt Dialysis Method
The salt dialysis method is the most widely used approach for assembling nucleosomes from purified histones and DNA. It exploits the fact that histones and DNA interact non-specifically at high salt concentrations but form specific nucleosome complexes as the salt concentration is gradually reduced.
Protocol outline:
- Prepare histones and DNA: Mix recombinant histone octamers (or individual histones) with DNA at a molar ratio of approximately 0.8–1.0 octamer per 147 bp DNA in a high-salt buffer (2 M NaCl, 10 mM Tris–HCl pH 7.5, 1 mM EDTA, 1 mM DTT).
- Dialysis: Dialyze the mixture against buffers with decreasing salt concentrations. A typical gradient is:
- 2 M NaCl for 2 hours
- 1.2 M NaCl for 2 hours
- 0.8 M NaCl for 2 hours
- 0.6 M NaCl for 2 hours
- 0.4 M NaCl for 2 hours
- 0.2 M NaCl for 2 hours
- Final dialysis in 0.1 M NaCl or low-salt buffer (e.g., 10 mM Tris–HCl pH 7.5, 1 mM EDTA) overnight at 4°C.
- Quality check: Analyze the assembly products by native PAGE or other methods (see Section 5).
The salt dialysis method produces nucleosomes with high yield and is suitable for assembling nucleosomes on both short (147 bp) and long (multi-kilobase) DNA templates. However, it requires careful optimization of the salt gradient and histone-to-DNA ratio to avoid aggregation.
Assembly with Histone Chaperones
Chaperone-mediated assembly is an alternative to salt dialysis that more closely mimics the in vivo process. In this method, histones are pre-bound to chaperones such as NAP1 or ASF1, and assembly is initiated by the addition of DNA.
Protocol outline:
- Prepare histone–chaperone complexes: Incubate recombinant H3–H4 and H2A–H2B with NAP1 (for H2A–H2B) or ASF1 (for H3–H4) in a low-salt buffer (e.g., 20 mM Tris–HCl pH 7.5, 150 mM NaCl, 1 mM DTT) for 30 minutes on ice.
- Add DNA: Add the DNA template to the histone–chaperone mixture and incubate at 30°C for 1–2 hours.
- Optional remodeler treatment: For regularly spaced nucleosome arrays, add ISWI or CHD1 remodelers along with ATP (1 mM) and MgCl₂ (3 mM) and incubate for an additional 1–2 hours.
- Purify: Remove chaperones and unassembled components by gel filtration or by binding to a cation-exchange resin.
Chaperone-mediated assembly is gentler than salt dialysis and is preferred for assembling nucleosomes with histone variants or post-translationally modified histones, which may be unstable at high salt concentrations.
Recombinant Histone Preparation
Recombinant histones are typically expressed in E. coli as inclusion bodies, purified under denaturing conditions, and refolded into octamers or dimers.
Protocol outline:
- Expression: Express each histone (H2A, H2B, H3, H4) in E. coli (e.g., BL21(DE3) cells) using a pET vector. Induce with 0.5 mM IPTG at 37°C for 3 hours.
- Inclusion body isolation: Lyse cells by sonication in lysis buffer (50 mM Tris–HCl pH 7.5, 100 mM NaCl, 1 mM EDTA, 1 mM DTT, 1 mM PMSF). Centrifuge at 20,000 × g for 20 minutes. Wash the pellet twice with wash buffer (50 mM Tris–HCl pH 7.5, 100 mM NaCl, 1 mM EDTA, 1% Triton X-100) and once with wash buffer without Triton.
- Solubilization: Dissolve inclusion bodies in unfolding buffer (7 M guanidinium chloride, 20 mM Tris–HCl pH 7.5, 1 mM DTT) at a protein concentration of ~10 mg/mL.
- Refolding octamers: Mix the four histones in equimolar ratios (based on OD₂₈₀ measurements) and dialyze against refolding buffer (2 M NaCl, 10 mM Tris–HCl pH 7.5, 1 mM EDTA, 5 mM 2-mercaptoethanol) at 4°C for at least 12 hours.
- Purification: Purify the refolded octamer by gel filtration (e.g., Superdex 200) in refolding buffer. The octamer elutes as a single peak at ~200 kDa.
Proper refolding is critical; misfolded histones aggregate and fail to assemble into nucleosomes. Always verify octamer integrity by SDS-PAGE and, ideally, by circular dichroism spectroscopy.
Assessing Nucleosome Assembly Quality
Verifying that nucleosome assembly has succeeded is essential before proceeding with downstream experiments. Several complementary methods are available.
Native PAGE and Gel Shift Assays
Native polyacrylamide gel electrophoresis (PAGE) is the simplest and most common method for assessing nucleosome assembly. Nucleosomes migrate more slowly than free DNA due to their larger size and reduced negative charge density.
Protocol:
- Prepare a 5% native polyacrylamide gel (39:1 acrylamide:bis-acrylamide) in 0.5× TBE (45 mM Tris-borate, 1 mM EDTA).
- Load 100–500 ng of assembled nucleosomes mixed with loading buffer (10% glycerol, 0.01% bromophenol blue).
- Electrophorese at 100 V for 1–2 hours at 4°C.
- Stain with ethidium bromide or SYBR Gold and visualize.
A successful assembly yields a single, discrete band that migrates slower than free DNA. Smearing or multiple bands indicate incomplete assembly or aggregation. For nucleosomes assembled on 147 bp DNA, the nucleosome band typically migrates at approximately 1.5–2× the position of free DNA.
Micrococcal Nuclease (MNase) Digestion
MNase digestion is used to assess the regularity and spacing of nucleosomes, particularly in arrays. MNase preferentially cleaves linker DNA between nucleosomes, leaving the 147 bp core protected.
Protocol:
- Incubate assembled nucleosomes (1–5 µg) with MNase (0.1–1 U) in digestion buffer (10 mM Tris–HCl pH 7.5, 10 mM NaCl, 3 mM CaCl₂) at 37°C.
- Remove aliquots at 0, 1, 2, 5, 10, and 20 minutes; stop the reaction by adding EDTA to 10 mM final concentration.
- Purify the DNA by phenol-chloroform extraction and ethanol precipitation.
- Analyze on a 1.5% agarose gel.
A ladder of DNA fragments with a repeating unit of ~180–200 bp (for arrays) or a single ~147 bp band (for mononucleosomes) indicates proper assembly. The presence of sub-nucleosomal fragments suggests incomplete wrapping or histone loss.
Topoisomerase I Supercoiling Assay
The supercoiling assay is a powerful method for assessing nucleosome assembly on circular plasmid DNA. When nucleosomes assemble on closed circular DNA, they introduce negative supercoils. Topoisomerase I relaxes the DNA, and after deproteinization, the number of supercoils corresponds to the number of assembled nucleosomes.
Protocol:
- Assemble nucleosomes on relaxed plasmid DNA (e.g., pUC19) using salt dialysis or chaperone-mediated assembly.
- Add topoisomerase I (5 U per µg DNA) and incubate at 37°C for 1 hour in topoisomerase buffer (10 mM Tris–HCl pH 7.5, 50 mM KCl, 5 mM MgCl₂, 1 mM DTT).
- Stop the reaction by adding SDS to 0.5% and proteinase K to 100 µg/mL; incubate at 55°C for 1 hour.
- Purify the DNA and analyze on a 1% agarose gel containing 1 µg/mL chloroquine to resolve topoisomers.
Each nucleosome introduces approximately one negative supercoil. The number of topoisomers resolved by gel electrophoresis therefore directly reflects the number of nucleosomes assembled. This assay is particularly useful for quantifying assembly efficiency on long DNA templates.
Nucleosome Assembly in the Cell: Replication-Coupled vs. Replication-Independent
Replication-Coupled Assembly (RCA)
RCA is the dominant pathway for nucleosome assembly during S phase. As the replication fork progresses, parental histones are displaced and recycled, while newly synthesized histones are deposited onto the daughter strands. The process is tightly coordinated with DNA synthesis:
- Histone synthesis and modification: Newly synthesized H3–H4 dimers are acetylated on H4 K5 and K12 by Hat1, and on H3 K56 by the acetyltransferase Rtt109 in yeast (or its homologs in higher eukaryotes). These modifications promote chaperone binding and deposition.
- Chaperone loading: ASF1 binds the modified H3–H4 dimers and delivers them to CAF-1 at the replication fork.
- PCNA-mediated deposition: CAF-1 interacts with PCNA, which is loaded onto DNA by the replication factor C (RFC) complex. This interaction ensures that histone deposition occurs immediately behind the replication fork.
- H2A–H2B deposition: NAP1 or other H2A–H2B chaperones deliver dimers to complete the nucleosome.
RCA is essential for maintaining chromatin integrity during replication. Defects in CAF-1 or ASF1 lead to replication stress, DNA damage, and loss of epigenetic marks.
Replication-Independent Assembly (RIA)
RIA occurs throughout the cell cycle and is responsible for replacing histones that are lost during transcription, DNA repair, or other chromatin-templated processes. The HIRA complex is the primary chaperone for RIA, depositing H3.3–H4 dimers at transcriptionally active loci.
RIA also involves the deposition of histone variants such as H2A.Z, which is incorporated at promoters and enhancers by the SWR1 remodeler complex. H2A.Z deposition is important for gene regulation and genome stability.
The distinction between RCA and RIA is not absolute; some overlap exists, and certain chaperones can participate in both pathways. However, the division is conceptually useful and reflects the different histone sources and deposition sites involved.
Regulation and Quality Control of Nucleosome Assembly
Histone Modifications and Assembly
Histone post-translational modifications (PTMs) play critical roles in regulating nucleosome assembly. Acetylation of newly synthesized histones is particularly important:
- H4 K5 and K12 acetylation: These marks are added by Hat1 and are recognized by CAF-1, promoting deposition during RCA.
- H3 K56 acetylation: This modification is added by Rtt109 in yeast and by CBP/p300 in humans. It is located near the DNA entry-exit point of the nucleosome and is thought to destabilize histone–DNA interactions, facilitating assembly and disassembly.
- H3 K9 and K27 methylation: These marks are associated with transcriptional silencing and are established after nucleosome assembly, contributing to the maintenance of heterochromatin.
Histone modifications also regulate the activity of chaperones and remodelers. For example, the bromodomain of the remodeler BRG1 recognizes acetylated histones, targeting it to active chromatin.
Histone Variants (H3.3, CENP-A)
Histone variants add another layer of regulation to nucleosome assembly. H3.3 differs from canonical H3 by only four amino acids but is deposited in a replication-independent manner by HIRA. H3.3 is enriched at transcription start sites, enhancers, and telomeres, and its deposition is associated with active chromatin.
CENP-A is a centromere-specific H3 variant that is essential for kinetochore assembly and chromosome segregation. CENP-A deposition is mediated by the chaperone HJURP (Holliday junction recognition protein) and occurs specifically during the G1 phase of the cell cycle. The mechanisms that restrict CENP-A deposition to centromeres are not fully understood but involve the recognition of existing CENP-A nucleosomes and the activity of specific remodelers.
The Nucleosome Concept has evolved to encompass these variants, which create specialized chromatin domains with distinct functional properties. Understanding how variants are assembled and maintained is a major focus of current research.
Common Pitfalls and Troubleshooting in Nucleosome Assembly Experiments
Histone Aggregation and Solubility
Histone aggregation is the most common problem in in vitro assembly. Histones are highly basic proteins (pI > 10) and tend to aggregate at low salt concentrations or when their concentration exceeds ~2 mg/mL.
Symptoms: Visible precipitation, smearing on native gels, or low yields of assembled nucleosomes.
Solutions:
- Keep histones in high-salt buffers (≥2 M NaCl) until the assembly step.
- Use fresh DTT or 2-mercaptoethanol to prevent oxidation of cysteine residues.
- Centrifuge histone stocks at 20,000 × g for 10 minutes at 4°C before use to remove aggregates.
- Reduce histone concentration to ≤1 mg/mL during refolding.
- Add 0.01% NP-40 or 0.1 mg/mL BSA to assembly reactions to reduce non-specific interactions.
Optimizing Salt Gradient
The salt dialysis method is sensitive to the rate of salt removal. If the salt concentration drops too quickly, histones and DNA precipitate before proper nucleosome assembly can occur.
Symptoms: Aggregates visible during dialysis, low nucleosome yield, or high background on gels.
Solutions:
- Extend the dialysis time at each salt concentration (e.g., 4 hours instead of 2).
- Use a stepwise gradient with smaller decrements (e.g., 0.2 M steps instead of 0.4 M).
- Perform the final dialysis step against a buffer containing 0.1 M NaCl rather than salt-free buffer.
- Consider using a peristaltic pump to create a continuous salt gradient over 12–24 hours.
Avoiding Nuclease Contamination
Nuclease contamination degrades the DNA template and produces smeared or fragmented nucleosomes.
Symptoms: DNA degradation visible on agarose gels, loss of the 147 bp protected fragment in MNase assays.
Solutions:
- Use nuclease-free water and buffers.
- Add EDTA (1 mM) to all buffers to chelate Mg²⁺, which is required for most nucleases.
- Include protease inhibitors (e.g., 1 mM PMSF, 1 µg/mL leupeptin) in histone preparations to prevent proteolytic degradation that can release nucleases.
- Filter-sterilize all buffers and use fresh DNA preparations.
- Test all components for nuclease activity by incubating with plasmid DNA and analyzing by agarose gel electrophoresis.
Incomplete Assembly
Incomplete assembly results in nucleosomes that lack one or more histone dimers, producing sub-nucleosomal particles.
Symptoms: Multiple bands on native gels, or a smear between the free DNA and nucleosome positions.
Solutions:
- Titrate the histone-to-DNA ratio. The optimal ratio varies with DNA length and sequence; test ratios from 0.5:1 to 1.5:1 (octamer:DNA).
- For salt dialysis, ensure that the starting salt concentration is ≥2 M NaCl to fully dissociate histones.
- For chaperone-mediated assembly, increase the incubation time or temperature (up to 37°C).
- Add a heat-shock step (e.g., 10 minutes at 42°C) after assembly to promote nucleosome maturation.
Incorrect Nucleosome Positioning
Nucleosomes assembled in vitro may occupy multiple positions on the DNA, leading to heterogeneous products.
Symptoms: Broad or multiple bands on native gels, or a ladder of fragments in MNase assays.
Solutions:
- Use DNA templates with strong positioning sequences, such as the 601 Widom sequence, which has a high affinity for the histone octamer at a defined position.
- For longer DNA, include an ATP-dependent remodeler (e.g., ISWI) during assembly to promote repositioning.
- Perform a "salt gradient plus remodeler" protocol: assemble at moderate salt, then add remodeler and ATP to allow nucleosomes to slide to their preferred positions.
Summary and Future Directions
Nucleosome assembly is a fundamental process that packages the genome and regulates DNA accessibility. The core mechanisms—histone chaperone-mediated delivery, stepwise octamer formation, and ATP-dependent remodeling—are conserved from yeast to humans. In vitro assembly methods, particularly salt dialysis and chaperone-mediated assembly, have enabled detailed biochemical and structural studies of nucleosomes and their complexes.
Despite significant progress, many questions remain. How are histone modifications and variants coordinated during assembly to establish epigenetic states? What are the precise dynamics of nucleosome assembly at replication forks? How do chromatin remodelers achieve specificity for their targets? Advances in single-molecule imaging, cryo-electron microscopy, and genome-wide approaches are beginning to address these questions.
The Nucleosome Model continues to evolve as new data reveal the complexity of chromatin dynamics. Understanding nucleosome assembly is not only of fundamental interest but also has practical implications for regenerative medicine, epigenome editing, and cancer therapy, where manipulating chromatin states holds therapeutic promise.
Frequently Asked Questions
What are the steps of nucleosome assembly?
Nucleosome assembly proceeds through three main steps: (1) formation of the H3–H4 tetramer, which binds DNA first; (2) sequential addition of two H2A–H2B dimers to complete the octamer; and (3) progressive wrapping of ~147 bp of DNA around the histone core. In cells, these steps are facilitated by histone chaperones and ATP-dependent remodelers, which ensure proper timing and spacing.
What is the nucleosome assembly protocol for in vitro experiments?
The most common protocol is salt dialysis. Mix purified histone octamers with DNA in 2 M NaCl, then dialyze stepwise against buffers with decreasing salt concentrations (2 M → 1.2 M → 0.8 M → 0.6 M → 0.4 M → 0.2 M → 0.1 M NaCl) over 12–24 hours at 4°C. Alternatively, use chaperone-mediated assembly by pre-incubating histones with NAP1 or ASF1 and then adding DNA in low salt.
What is the role of histone chaperones in nucleosome assembly?
Histone chaperones bind histones and prevent their non-specific aggregation with DNA. They deliver histones to the appropriate genomic locations and coordinate assembly with DNA replication or transcription. Key chaperones include CAF-1 (replication-coupled H3–H4 deposition), HIRA (replication-independent H3.3 deposition), and NAP1 (H2A–H2B deposition).
How do you check if nucleosome assembly worked?
Common quality checks include: (1) native PAGE, which shows a discrete slow-migrating band for assembled nucleosomes; (2) MNase digestion, which yields a protected ~147 bp DNA fragment; and (3) topoisomerase I supercoiling assay, which quantifies the number of nucleosomes by the number of supercoils introduced into circular DNA.
What is the difference between replication-coupled and replication-independent nucleosome assembly?
Replication-coupled assembly (RCA) occurs during S phase and uses newly synthesized histones deposited by CAF-1 behind the replication fork. Replication-independent assembly (RIA) occurs throughout the cell cycle, uses the HIRA complex to deposit H3.3–H4 dimers, and is important for replacing histones at transcriptionally active loci.
Why do my histones aggregate during assembly?
Histone aggregation is usually caused by low salt concentrations, high histone concentrations, or oxidized cysteine residues. Keep histones in ≥2 M NaCl, use fresh reducing agents, and maintain histone concentrations below 2 mg/mL. Centrifuge stocks before use and consider adding 0.01% NP-40 to reduce non-specific interactions.
What are the key components needed for nucleosome assembly in vitro?
The essential components are purified histone octamers (or individual histones), a DNA template (e.g., 147 bp 601 sequence or plasmid DNA), and appropriate buffers (Tris–HCl pH 7.5, NaCl, EDTA, DTT). For chaperone-mediated assembly, add NAP1, ASF1, or CAF-1. For spaced arrays, include an ATP-dependent remodeler such as ISWI or CHD1 and ATP.
Key Takeaways
- Nucleosome assembly is the process of wrapping ~147 bp of DNA around a histone octamer, and it is essential for genome packaging and gene regulation.
- Two major cellular pathways exist: replication-coupled assembly (RCA) mediated by CAF-1 and PCNA, and replication-independent assembly (RIA) mediated by HIRA.
- Histone chaperones such as ASF1, CAF-1, NAP1, and HIRA prevent histone aggregation and direct deposition to specific genomic sites.
- In vitro assembly methods include salt dialysis, which is simple and robust, and chaperone-mediated assembly, which is gentler and better for modified or variant histones.
- Quality assessment requires multiple methods: native PAGE for size, MNase digestion for protection, and supercoiling assays for quantification.
- Common pitfalls include histone aggregation, incomplete assembly, nuclease contamination, and incorrect positioning; these can be addressed by optimizing salt gradients, histone-to-DNA ratios, and using strong positioning sequences.
- Histone variants (H3.3, CENP-A) and post-translational modifications add regulatory complexity to assembly, linking chromatin structure to cellular function.
Further Reading
- Robert F, Jeronimo C. Transcription-coupled nucleosome assembly. Trends in biochemical sciences. 2023. PubMed 37657993
- Ito T. Nucleosome assembly and remodeling. Current topics in microbiology and immunology. 2003. PubMed 12596902
- Xu M, Zhu B. Nucleosome assembly and epigenetic inheritance. Protein & cell. 2010. PubMed 21203924
- Laskey RA, Earnshaw WC. Nucleosome assembly. Nature. 1980. PubMed 6250082
- Liu CP et al. Structural insights into histone binding and nucleosome assembly by chromatin assembly factor-1. Science (New York, N.Y.). 2023. PubMed 37616371
- Zhang W, Feng J, Li Q. The replisome guides nucleosome assembly during DNA replication. Cell & bioscience. 2020. PubMed 32190287